Direct healthcare company, Nomi Health, and South Carolina-based ClearPoint Health have partnered to help small and mid-sized employers across the US take better control of their health insurance costs.
ClearPoint develops and scales clinically integrated captives, including clinical providers in the sponsorship of medical stop loss captives.
The product, CliniCaptive, is built for provider organisations to offer more affordable insurance to their local employers.
“Together with ClearPoint Health, we’re simplifying how healthcare is paid for and delivered, and we take pride in passing these savings onto small and mid-sized employers, so they can provide an affordable plan to their employees and families,” said Mark Newman, CEO and co-founder of Nomi Health.
Using the CliniCaptive product, Nomi will feature its platform of services, including network of provider partners, pharmacy solutions, revenue cycle management, member navigation services, and reporting and analytics suite.
ClearPoint and Nomi will be launching their partnership product across at least four regions in over 15 states in 2024, with expansion planned for early 2025.
Over 50 health systems are expected to participate in select geographies over the next year.
“ClearPoint’s medical stop loss captive integrates perfectly with Nomi’s service platform,” said Jeb Dunkelberger.
“Together, we’re able to partner with more provider organisations and health systems as we aggregate employers seeking an alternative insurance solution that offers sustainable affordability.”
In October, Dunkelberger told Captive Intelligence that there is no end in sight when it comes to current US health insurance challenges, with SMEs disproportionally being impacted.